Y501-1793 Screening compound: 9-(difluoromethyl)-2-[2-(3-nitro-1H-pyrazol-1-yl)ethyl]-7-phenylpyrido[3',2':4,5]thieno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidine

Y501-1793 Screening compound: 9-(difluoromethyl)-2-[2-(3-nitro-1H-pyrazol-1-yl)ethyl]-7-phenylpyrido[3',2':4,5]thieno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidine
Y501-1793 Screening compound: 9-(difluoromethyl)-2-[2-(3-nitro-1H-pyrazol-1-yl)ethyl]-7-phenylpyrido[3',2':4,5]thieno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidine alternative view

Chemical Structure Depiction of ChemDiv screening compound Y501-1793
9-(difluoromethyl)-2-[2-(3-nitro-1H-pyrazol-1-yl)ethyl]-7-phenylpyrido[3',2':4,5]thieno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y501-1793

Molecular Formula

C22H14F2N8O2S (C22 H14 F2 N8 O2 S)

Compound Name

9-(difluoromethyl)-2-[2-(3-nitro-1H-pyrazol-1-yl)ethyl]-7-phenylpyrido[3',2':4,5]thieno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidine

IUPAC name

13-(difluoromethyl)-4-[2-(3-nitro-1H-pyrazol-1-yl)ethyl]-11-phenyl-16-thia-356814-pentaazatetracyclo[7.7.0.0^{26}.0^{1015}]hexadeca-1(9)24710(15)1113-heptaene

SMILES

[O-][N+](c1nn(CCc2nn(cnc3c4sc5nc(C(F)F)cc(-c6ccccc6)c35)c4n2)cc1)=O

InChI

InChI=1S/C22H14F2N8O2S/c23-20(24)14-10-13(12-4-2-1-3-5-12)17-18-19(35-22(17)26-14)21-27-15(28-31(21)11-25-18)6-8-30-9-7-16(29-30)32(33)34/h1-5,7,9-11,20H,6,8H2

InChI Key

NKGVCRQDVBFYST-UHFFFAOYSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

492.47

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.770

Distribution Coefficient, logD

3.767

Water Solubility, LogSw

-4.25

Polar Surface Area

88.423

Acid Dissociation Constant (pKa)

23.76

Base Dissociation Constant (pKb)

5.27

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.64

Y501-1793 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with Y501-1793 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y501-1793?
Check Price and Availability of Y501-1793, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y501-1793 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y501-1793
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y501-1793
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y501-1793 available by request